More than 10 months after U.S. regulators first authorized its potent shot, Moderna is finding that inventing a COVID-19 vaccine was actually a relatively straightforward task compared with what would come next: ramping up vial-filling operations on multiple continents and distributing the vaccine to countries around the world in the middle of a devastating pandemic.
The Council of Supply Chain Management Professionals (CSCMP) and SupplyChainBrain presented their annual Supply Chain Innovation Award on Wednesday to global health care nonprofit Management Sciences for Health’s (MSH) for streamlining distribution of HIV and TB medicines to vulnerable communities in Ukraine.
The U.S. plan for boosters will steer tens of millions of doses into the arms of many U.S. adults starting as soon as Friday. That’s angered nations where many people are still struggling to obtain a first shot.
Michael Einhorn, chief executive officer of medical supplier Dealmed, explains how the healthcare purchasing system frustrates attempts to diversify sourcing of personal protective equipment and head off future shortages in times of emergency.
As U.S. regulatory approval of Pfizer Inc.’s COVID-19 shot paves the way for companies to get more aggressive with inoculations, American workers are increasingly supportive of punitive measures for unvaccinated colleagues.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.